Health Spending Package Stalls in Senate, Federal Shutdown Looms

An exterior shot of the U.S. Capitol.
The U.S. Senate continued negotiations Thursday on a series of House-passed federal spending bills.
The U.S. Senate continued negotiations Thursday on a series of House-passed federal spending bills, putting the fate of a bipartisan-backed [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

CMS Selects Drugs for Next Round of Medicare Negotiations; This Time Including Part B Products 

A screenshot of CMS' fact sheet on the 2028b IPAY drugs.
CMS announced the latest round of high-cost prescription drugs covered under Medicare Part D—and for the first time—Part B chosen for price negotiations under the IRA.
The Trump administration on Tuesday announced the latest round of high-cost prescription drugs covered under Medicare Part D—and for the [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Federal Judge Rejects Third Drug Industry Challenge to Maine’s 340B Contract Pharmacy Access Law

The Maine state capitol
A federal judge allowed Maine's 340B contract pharmacy access law to remain in effect after denying the third drug industry bid to block it.
A federal judge on Friday denied a drug industry trade group’s request to block enforcement of Maine’s 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Arizona Republican Introduces 340B Contract Pharmacy Bill, Draws Dark Money Opposition

A photo of the Arizona state capitol
An Arizona state representative recently introduced a bill prohibiting manufacturers from restricting 340B contract pharmacy access.
An Arizona state Republican recently introduced a 340B contract pharmacy access bill—and he has already drawn the ire of a [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Kansas Introduces 340B Hospital Reporting Bill Amid Stalled Contract Pharmacy Legislation 

The Kansas state capitol.
A Kansas House committee recently introduced legislation requiring state hospitals to annually report on their 340B programs.
Kansas House lawmakers recently introduced a 340B hospital reporting bill—while a separate Senate-approved 340B contract pharmacy access bill remains stalled [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

HHS Releases New Guidance for Direct-to-Consumer Drug Sales

A screenshot of the HHS OIG's Jan. 27 bulletin on direct-to-consumer sales.
The HHS Office of Inspector General published a Jan. 27 bulletin detailing how drugmakers can take advantage of direct-to-consumer sales to patients with federal health care coverage.
Pharmaceutical manufacturers can sell prescription drugs directly to patients—including Medicare and Medicaid enrollees—who choose to pay with cash as long [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

State Contract Pharmacy Roundup: Actions in Utah, Maine, New Mexico and Oregon

A lawyer writes
Lawsuits against contract pharmacies saw movement in Utah, Maine, New Mexico and Oregon.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »
Expert Tip

Expert Tip from Ravin Consultants

img

TIP: Make your FQHC’s 340B pharmacy access visible by consistently communicating low-cost medication options at scheduling, intake, and care coordination touchpoints.

Read More »

Large Hospital Group Asks HRSA to Immediately Block Lilly’s 340B In-House Pharmacy Claims Data Policy

A screenshot of AHA's Jan. 26 letter to HRSA
The American Hospital Association urged HRSA to take enforcement action against Eli Lilly's new 340B claims data policy.
The American Hospital Association (AHA) on Monday asked federal regulators to “take any and all available enforcement action” to halt [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

340B Lobbying Remained Strong in Final Quarter of 2025, Disclosure Filings Show

A chart showing "340B" lobbying filings made in each quarter of 2025.
More than 310 firms listed the 340B program in their fourth quarter lobbying disclosure forms that were due Jan. 20.
The 340B program continued to draw heavy lobbying attention on Capitol Hill in the final months of 2025, as a [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live